Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.
Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment.
Self-tolerance in multiple sclerosis.
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions.
Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.
A case with neuromyelitis optica mimicking Susac's syndrome.
MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: Commentary.
Developing a community multiple sclerosis nursing service.
Simvastatin affects cell motility and actin cytoskeleton distribution of microglia.
Regional anesthesia in patients with pre-existing neurologic disease.
C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: treatment with rituximab.
TH17 cell differentiation is regulated by the circadian clock.
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.
dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.
Comparative validity of accelerometer based measures of physical activity for people with multiple sclerosis.
Altered collagen expression in jugular veins in multiple sclerosis.
Closing the clinical-radiological paradox using the visual pathway in multiple sclerosis.
Effect of fingolimod (FTY720) on cerebral blood flow, platelet function, and macular thickness in healthy volunteers.
Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder.
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
Immunosuppressive monoclonal antibodies: current and next generation.
Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.
Effect of virtual reality-based balance training in multiple sclerosis.
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Pages